Cloud Control LLC · Project DNaIBuilt for Flare Summer Signal · Confidential Compute Apps (FTSOv2 + FDC)

Your genome
is an asset.
You should own it.

DNaI is the genomic sovereign token — a blockchain-native instrument that transforms every human’s genetic code into a verifiable, ownable, and monetizable digital asset. Your DNA. Your data. Your sovereignty.

Runs on Flare’s Coston2 testnet with simulated data.

8B+

Genomic Assets

100%

Data Brokers Eliminated

Always

Sovereign By Design

What is DNaI

A genomic sovereign token for every human on Earth. The first blockchain instrument designed to make your genetic code a recognized, auditable, and compensated digital asset.

Today, genomics companies, research institutions, and data brokers extract enormous value from your DNA — without your meaningful consent and without compensating you. DNaI reverses the equation: through on-chain tokenization, zero-knowledge proofs, and smart contract-governed access, every human being can assert sovereign ownership over their most intimate data and participate in the value it creates.

The Problem

Your DNA is worth billions. You receive nothing.

The global genomics market is projected to exceed $62 billion by 2028. The raw material driving that growth is human genetic data — collected through consumer ancestry tests, hospital systems, and research studies, then sold, licensed, and leveraged for pharmaceutical development, insurance risk modeling, and AI training.

The individuals whose genomes power this economy are invisible stakeholders. They sign away rights in dense legal agreements, receive no ongoing royalties, and have no mechanism to revoke access or audit who holds their most sensitive biological data.

DNaI exists to change that — permanently and provably.

$62B+

Genomics market value by 2028 — built on your data.

0%

Share of that value returned to the individuals whose genomes power it.

500M+

Human genomes already held by private databases with no reversion rights.

0

Blockchain-verified consent mechanisms in mainstream genomics today.

How DNaI Works

From genome to sovereign digital asset.

A clear, cryptographically verifiable path from biological sequence to blockchain-anchored ownership and ongoing economic participation.

01

Sequence & Vault

Your genomic data is encrypted client-side and stored in a sovereign personal data vault — a zero-knowledge container that only you can authorize access to.

02

Tokenize Sovereignty

A unique DNaI token is minted on-chain as immutable, verifiable proof that you hold exclusive sovereign rights over your genetic code. One genome, one token.

03

Authorize & Earn

Choose who accesses your data — research institutions, pharma companies, personalized medicine platforms — and receive royalties automatically for every authorized use.

04

Govern the Future

DNaI holders vote on data usage policies, research ethics, token issuance, and the standards governing the global genomic data economy.

The demo

Medical AI without exposing
your DNA.

See why genomic privacy and AI-powered medicine don’t have to be in conflict — and how DNaI makes both possible.

Try it live · interactive

The Sovereign Genomic Wallet

Switch between owner and researcher, request access to a segment, sign under 2-of-3 multisig custody, and revoke a live grant — end to end, on Flare’s Coston2 testnet with simulated data.

Launch interactive demo →

Coston2 testnet · simulated data · no real genome is used

Applications

The sovereign genomic economy.

DNaI unlocks a new layer of the bioeconomy — one where individuals participate as recognized stakeholders across every sector that touches their genetic data.

Pharmaceutical Research

Pharma companies pay DNaI holders directly for consented access to genomic datasets — eliminating exploitative data brokers and intermediaries.

Personalized Medicine

Enable healthcare providers to access your verified genomic profile with your consent for precision diagnostics and individualized treatment.

Clinical Trials

Streamline trial recruitment and compensate participants fairly through smart contract-governed, fully auditable access agreements.

AI & Genomic Models

AI companies building genomic foundation models must obtain consent and compensate DNaI holders — ending unauthorized training data harvesting.

Ancestry & Heritage

Verifiable genomic identity anchored to a sovereign on-chain record — your lineage, your heritage, recognized as a digital asset.

Insurance & Risk

Consent-gated genomic risk assessment with tamper-evident audit trails protecting individual rights throughout every data interaction.

Claim your genomic sovereignty.
Before someone else does.

DNaI is in active development. Subscribe for early access, token-design and roadmap updates, an invitation to the genesis token event, and a say in the policies governing the world’s first sovereign genomic economy.

What the token carries

  • Sovereign OwnershipOne DNaI per verified human genome — non-fungible proof of biological sovereignty recorded on an immutable ledger.
  • Access RoyaltiesSmart contracts distribute earnings automatically every time an authorized party accesses your genomic data.
  • On-Chain ConsentEvery access event is immutably recorded on-chain. Full transparency. Full auditability. Full control.
  • Governance RightsToken holders vote on platform policy, research ethics standards, and protocol upgrades through a decentralized DAO.
  • Privacy by DefaultZero-knowledge proofs enable data utility for researchers without ever exposing raw genomic sequences.
  • InteroperableDNaI integrates with EHR systems, research platforms, and existing healthcare infrastructure across jurisdictions.

Where it’s going

  1. Phase I FoundationGenomic vault architecture · DNaI token standard development · Regulatory engagement & legal framework · Pilot partner selection
  2. Phase II Proof of SovereigntyClosed beta — first 1,000 genomes vaulted · On-chain consent layer live · First pharmaceutical data-access agreements · DNaI token genesis event
  3. Phase III Open NetworkPublic mainnet launch · EHR & research platform integrations · Global expansion — 50+ jurisdictions · Governance DAO activation
  4. Phase IV The Genomic EconomyUniversal genomic identity standard · Multi-omics support (proteomics, epigenomics) · AI model licensing marketplace · Sovereign genomic data index

A Cloud Control LLC project · GBA Blockchain Maturity Model Certified